Just hours after the WHO declared the end of Ebola virus transmission in the outbreak region, the agency confirms a new, fatal case.
The WHO also warned of the risk of flare-ups due to ligering virus in some survivors, a threat it says will decline with time.
Experts called together in the wake of the Ebola crisis laid out ways to better prepare for the next threat.
According to the first-ever global burden estimates for melioidosis, the disease is sharply underreported in 45 endemic countries, it's probably endemic in 34 more, and conditions are suitable for the disease in parts of the United States and Japan.
Johnson & Johnson's prime-boost Ebola vaccine regimen is entering phase 2 clinical trials in both healthy and HIV-infected people, the Walter Reed Army Institute of Research (WRAIR) announced yesterday in a press release.
Also, a short report notes gender differences during the outbreak, such as higher survival in females.
Social networks, though, were strong in poorer areas, which helped with disease control.
Forty-two days (two incubation periods) after its last Ebola patient tested negative for the virus, Guinea has been declared Ebola-free by the World Health Organization (WHO), leaving only Liberia to achieve that status in the outbreak region of West Africa, the WHO said in a news release.
After going 9 days without reporting a MERS-CoV infection, Saudi Arabia's Ministry of Health (MOH) confirmed a case yesterday.
Researchers used detailed exams in survivors to document eye problems, a common finding.
